CNNMoney.com
Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Mutual Funds Taxes Ask the Expert Money 101 Autos Loan Center Best Places to Live Ask the Expert Millionaires in the Making Ultimate Guide to Retirement Retirement Calculators Best Funds Ask the Mole Best Places to Retire Personal Tech Big Tech Blog Techland Blog Sectors and Stocks Fortune 500 Techs Tech Talk 100 Best Places to Launch Ultimate Resource Guide Small Biz Makeovers FSB 100 Ask & Answer Fortune 500 Technology Investing Management Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts
TRADING
CENTER
NJ to lose more than 800 pharmaceutical jobs
More than 800 pharmaceutical jobs leaving New Jersey as part of major restructuring

NEW YORK (Associated Press) - More than 800 pharmaceutical jobs will be leaving New Jersey starting in August.

Most of the job cuts and transfers are part of major previously announced restructurings at Johnson & Johnson and Schering-Plough Corp. This week, the companies specified how many of those jobs would be lost at New Jersey locations.

Schering-Plough, based in Kenilworth, is cutting 500 jobs. New Brunswick-based J&J is eliminating 22 jobs at its Ortho Biotech unit in Bridgewater, shifting another 260 to its Centocor unit in Horsham, Pa., and cutting another 267 Ortho Biotect jobs outside New Jersey. Centocor and Ortho Biotech are consolidating their operations.

Both J&J and Schering-Plough face slumping sales for key drugs.

Meanwhile, Abbott Laboratories in Parsippany is cutting 83 jobs. Top of page

Copyright 2007 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.